Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mingfule vs Alteplase in Acute STEMI Thrombolysis (China, Phase IV)
CTR20150365Phase 4Completed
- Sponsor
- Guangzhou Mingkang Bioengineering
- Start
- May 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tenecteplase in acute ST-segment elevation myocardial infarction (STEMI), sponsored by Guangzhou Mingkang Bioengineering. Started May 2016; status: completed.
02
Drugs
tenecteplase
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on CTR20150365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150365.